AU7208698A - Canine ehrlichiosis immunogenic and diagnostic compositions and methods - Google Patents

Canine ehrlichiosis immunogenic and diagnostic compositions and methods

Info

Publication number
AU7208698A
AU7208698A AU72086/98A AU7208698A AU7208698A AU 7208698 A AU7208698 A AU 7208698A AU 72086/98 A AU72086/98 A AU 72086/98A AU 7208698 A AU7208698 A AU 7208698A AU 7208698 A AU7208698 A AU 7208698A
Authority
AU
Australia
Prior art keywords
immunogenic
methods
diagnostic compositions
canine ehrlichiosis
ehrlichiosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72086/98A
Inventor
Jack H. Carlson
Serge Leterme
Marc Mackowiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERIAL
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9703790A external-priority patent/FR2761158B1/en
Application filed by Merial SAS filed Critical Merial SAS
Publication of AU7208698A publication Critical patent/AU7208698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
AU72086/98A 1997-03-24 1998-03-23 Canine ehrlichiosis immunogenic and diagnostic compositions and methods Abandoned AU7208698A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9703790A FR2761158B1 (en) 1997-03-24 1997-03-24 METHOD AND TOOL FOR DIAGNOSING CANINE EHRLICHIOSIS
FR9703790 1997-03-24
US92032797A 1997-08-21 1997-08-21
US08920327 1997-08-21
PCT/EP1998/001646 WO1998042743A1 (en) 1997-03-24 1998-03-23 Canine ehrlichiosis immunogenic and diagnostic compositions and methods

Publications (1)

Publication Number Publication Date
AU7208698A true AU7208698A (en) 1998-10-20

Family

ID=26233425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72086/98A Abandoned AU7208698A (en) 1997-03-24 1998-03-23 Canine ehrlichiosis immunogenic and diagnostic compositions and methods

Country Status (2)

Country Link
AU (1) AU7208698A (en)
WO (1) WO1998042743A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
MXPA02000748A (en) * 1999-07-21 2003-07-14 Cornell Res Foundation Inc Ehrlichia canis genes and vaccines.
WO2005049794A2 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7842474B2 (en) 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
WO2006107924A2 (en) * 2005-04-04 2006-10-12 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infected from vaccinated animals)
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
EP2664344B1 (en) 2007-10-31 2019-02-27 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infection from vaccinated animals)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976860A (en) * 1995-06-06 1999-11-02 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods

Also Published As

Publication number Publication date
WO1998042743A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
AU6679098A (en) Method and device for mixing medical compositions
AU4038797A (en) Diagnostic compositions and devices utilizing same
AU6019898A (en) Devices for tissue repair and methods for preparation and use thereof
AU2911399A (en) Natural substance based agent
AU2317699A (en) Dental restoratives
AU2825597A (en) Elastomer compositions and methods
AU2091499A (en) Permeable compositions and methods for their preparation
AU2349399A (en) R-lansoprazole compositions and methods
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU7964398A (en) Dental formulation
AU8053898A (en) Immunogenic compositions
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU7401598A (en) Epoxide-amine dendrimers and the preparation and use thereof
AU1957797A (en) Zwitterionic compositions and methods as biological response modifiers
AUPP589398A0 (en) Immunogenic compositions and uses thereof
AU3687297A (en) Insecticidal composition
AU4876397A (en) Insecticidal compositions and methods
AU6464098A (en) Dental composition
AU7208698A (en) Canine ehrlichiosis immunogenic and diagnostic compositions and methods
EP1075184A4 (en) Compositions and methods for active vaccination
AU4981199A (en) Compositions and methods for modulating sexual activity
AU7525496A (en) Methods and compositions comprising glut-2 and glut-2 chimeras
HUP0000280A3 (en) Canine ob protein compositions and methods
AU5378599A (en) Oral formulation
AU9588398A (en) Vaccine compositions and methods of enhancing vaccine efficacy